(Press-News.org) Ehrapy is intended to fill a critical gap in the analysis of health data, says Lukas Heumos, one of the main developers and a scientist at the Institute of Computational Biology at Helmholtz Munich and the Technical University of Munich (TUM): “Until now, there have been no standardized tools for systematically and efficiently analyzing diverse and complex medical data. We’ve changed that with ehrapy.” The team behind ehrapy comes from biomedical research and has extensive experience in analyzing complex scientific datasets. “The healthcare sector faces similar challenges in data analysis as those working in laboratories,” noted Heumos at the start of the ehrapy project.
Exploratory Approach – Hypothesis-Free Analysis
Together with many other contributors, Heumos has used his expertise in scientific software development to create a solution for analyzing patient data: “Ehrapy can uncover new patterns and generate insights without needing to analyze the data based on a specific assumption or hypothesis.” This exploratory approach, says Heumos, is a unique feature of ehrapy.
Ehrapy allows researchers to sort, group, and analyze large, heterogeneous, and complex datasets without any pre-existing hypotheses. This opens up new insights that can then be explored further. Heumos explains: “The exploratory approach brings fresh perspectives to health data analysis. Due to their complexity and heterogeneity, these data are often not analyzed as effectively as they could be.” Ehrapy thus opens new avenues for making health data more useful for medical research and practice.
The Long-Term Goal: Routine Use in Clinical Practice
Ehrapy was designed as open-source software from the beginning. “It was important to us to make the software available to the scientific community from day one,” emphasizes Heumos. The software is available as a Python package on GitHub, an online platform for software development, and can be used and further developed by researchers worldwide.
Currently, ehrapy focuses on efficiently and quickly analyzing research datasets, such as those stored in large health research centers. “Routine use in clinical practice is a long-term goal, but for now, we are concentrating on providing the research community with a powerful tool,” says Heumos.
In the future, the team plans to provide standardized databases for electronic health records (EHRs). These databases will enable better integration and analysis of large volumes of medical data. Additionally, this will facilitate the development of EHR atlases that can serve as reference datasets for contextualizing and annotating new datasets.
A Long Journey
“Ehrapy enables comprehensive data analysis across systems, which can be a key step for future AI systems in medicine. I therefore hope for a relatively quick adoption at various sites,” says Prof. Fabian Theis, Director of the Institute of Computational Biology at Helmholtz Munich and TUM Professor: “Establishing such technologies in medicine is a lengthy process that can take decades. Our goal is to bridge the gap between biomedical research and practical application in medicine.” Theis further explains that the development team is focusing on exploratory data analysis methods in a holistic form to more easily reveal hidden connections. “We are also trying to support academic and commercial players in the healthcare sector.”
Ehrapy on GitHub: https://github.com/theislab/ehrapy
About Helmholtz Munich
Helmholtz Munich is a leading biomedical research center. Its mission is to develop breakthrough solutions for better health in a rapidly changing world. Interdisciplinary research teams focus on environmentally triggered diseases, especially the therapy and prevention of diabetes, obesity, allergies, and chronic lung diseases. With the power of artificial intelligence and bioengineering, researchers accelerate the translation to patients. Helmholtz Munich has around 2,500 employees and is headquartered in Munich/Neuherberg. It is a member of the Helmholtz Association, with more than 43,000 employees and 18 research centers the largest scientific organization in Germany. More about Helmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH): www.helmholtz-munich.de/en
END
Ehrapy: A new open-source tool for analyzing complex health data
2024-09-12
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Ozone pollution reduces tropical forest growth
2024-09-12
Ozone gas is reducing the growth of tropical forests – leaving an estimated 290 million tonnes of carbon uncaptured each year, new research shows.
The ozone layer in the stratosphere shields our planet from harmful ultraviolet radiation – and protecting it is one of the major successes of environmental action.
But ozone at ground level – formed by the combination of pollutants from human activities in the presence of sunlight – interferes with plants’ ability to absorb carbon dioxide. Ozone is also harmful to human health.
The new study, published in ...
Study finds doctors and patients interested in environmental impact of health care decisions
2024-09-12
BOSTON – Concerns about the environmental impact of healthcare decisions rarely enter into conversations between patients and physicians. However, evidence from a new study led by researchers at Dana-Farber Cancer Institute, shows there's broad interest in changing that.
In a series of focus groups conducted in different areas of the United States, doctors and patients expressed openness to considering environmental factors when discussing treatment options. The findings, presented in a paper published online today by Nature Climate Change, suggest that educating physicians about the environmental costs of treatment ...
Five key factors predict the response of cancer patients to immunotherapy
2024-09-12
Barcelona, 12 September 2024 – Immunotherapy has transformed cancer treatment in recent years by enabling the immune system to attack tumour cells. However, only 20-40% of patients respond positively to immunotherapy, and these rates vary across different types of cancer. Predicting which patients will respond to immunotherapy and which will not is currently a highly active area of research. Numerous studies conducted so far have focused on the specific characteristics of tumours, their microenvironment, or the patient's immune ...
Trilobite fossils from upstate New York reveal “extra” set of legs
2024-09-12
A new study finds that a trilobite species with exceptionally well-preserved fossils from upstate New York has an additional set of legs underneath its head. The research, led by the American Museum of Natural History and Nanjing University in China, suggests that having a fifth pair of head appendages might be more widespread among trilobites than once thought. Published today in the journal Palaeontology, the study helps researchers better understand how trilobite heads are segmented.
Trilobites are ...
Big algebras: A dictionary of abstract math
2024-09-12
Several fields of mathematics have developed in total isolation, using their own ‘undecipherable’ coded languages. In a new study published in PNAS, Tamás Hausel, professor of mathematics at the Institute of Science and Technology Austria (ISTA), presents “big algebras,” a two-way mathematical ‘dictionary’ between symmetry, algebra, and geometry, that could strengthen the connection between the distant worlds of quantum physics and number theory.
Technical Toolkit: Symmetry and commutativity, from esthetics to functionality
Symmetry is not just a question of esthetics and equilibrium, but also a highly recurrent feature throughout the domains ...
BMI’s relation to cancer therapy mortality risks not so straightforward
2024-09-12
While being overweight increases the risk of developing lifestyle-related diseases, there is a phenomenon known as the obesity paradox where a decreased risk of death has been seen during cancer therapy. However, that paradox might not be the trend for all cancer therapies, an Osaka Metropolitan University team reports in JAMA Network Open, a publication of the American Medical Association.
Led by graduate student Mr. Yasutaka Ihara and Professor Ayumi Shintani of the Graduate School of Medicine’s Department of Medical Statistics, ...
Kids in families with too much screen time struggle with language skills
2024-09-12
Screens have become ubiquitous in our daily lives — which means they’ve also become part of children’s lives too. So what effect does this have on children’s developing brains, especially critical language skills? To understand this, scientists in Estonia surveyed the parents of more than 400 children about their screen use, their children’s screen use, and their children’s language skills. They found that parents who use screens a lot also have children who use screens a lot, and that children’s higher screen time is associated with poorer language skills.
“Our ...
Medical College of Georgia scientists searching for new treatment target for diabetic retinopathy
2024-09-12
Scientists at the Medical College of Georgia at Augusta University are searching for a new treatment target for a common complication of diabetes that can cause retinal blood vessels to break down, leak, or become blocked.
Diabetic retinopathy is a serious eye disease and a leading cause of blindness that results when diabetes’ sustained high blood sugar levels cause damage to the retina – the part of the eye that detects light – over time. That can happen in a number of ways, from inflammation to overgrowth ...
High doses of some prescription stimulants tied to increased psychosis risk
2024-09-12
Prescribing rates for stimulants that treat attention-deficit/hyperactivity disorder (ADHD) have increased significantly over the past decade, with some of the largest increases reported during the COVID-19 pandemic. A new study of adult emergency department admissions at Mass General Brigham, led by McLean Hospital researchers, found that individuals who are taking high doses of amphetamine (e.g. Adderall) face more than a five-fold increased risk for developing psychosis or mania. Findings were published September 12th in the American Journal of Psychiatry.
Overall, individuals with past-month prescription amphetamine use had a greater likelihood of new-onset psychosis or mania ...
New national survey shows hesitancy about vaccines this fall
2024-09-12
With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall. The new data comes just as this year’s flu shot rolls out and following the FDA’s approval of an updated round of COVID-19 vaccines.
The national poll of 1,006 people found more than one-third (37%) have gotten vaccines in the past but do not plan to this year. The same percent of respondents said they don’t need any of the vaccines surveyed in the poll, including flu, COVID-19, pneumococcal and respiratory ...